Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
about
Rapid obtention of stable, bioluminescent tumor cell lines using a tCD2-luciferase chimeric construct.Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A.Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition"Glowing head" mice: a genetic tool enabling reliable preclinical image-based evaluation of cancers in immunocompetent allografts.In vivo imaging of human malignant mesothelioma grown orthotopically in the peritoneal cavity of nude miceMelanoma brain colonization involves the emergence of a brain-adaptive phenotypeExpression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effectsPreclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of originLoss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.Targeting of Topoisomerase I for Prognoses and Therapeutics of Camptothecin-Resistant Ovarian Cancer.MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer.Assessment of Immune Isolation of Allogeneic Mouse Pancreatic Progenitor Cells by a Macroencapsulation DeviceEGF Receptor Promotes Prostate Cancer Bone Metastasis by Downregulating miR-1 and Activating TWIST1.A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis.hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma.TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms.Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic lRescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.Illuminating progression: tracking melanoma metastasis in a gene therapy setting.Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases.Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.Basal-like breast cancer engages tumor-supportive macrophages via secreted factors induced by extracellular S100A4
P2860
Q33854934-28F65BE9-7879-4671-BDD8-AEF46343E071Q34115628-AC4E0AF8-8127-4A01-8DEB-EE8319651C29Q34243311-5649854A-97C5-4C1C-B1BF-847B88B25007Q34450094-1BBC88EF-96F2-48F1-8550-ECC885766629Q34771909-49D5A2F9-8D6C-4C95-8F36-8A8BCB2D5E57Q34971850-402E91E4-9CB2-4A39-BD43-9E75BA967ED0Q35022631-ED416F66-4781-4873-8372-3E622526ECBEQ35179487-4C1F3DB3-3FBA-4D71-BB52-45DDE2FFD421Q35573029-E74CB9BA-7539-49D9-8ECE-A865E4CC9D3DQ35711333-A2D5E530-D808-4A8A-B903-FBCEEDD62D5CQ35906143-B29A5AE1-7A37-4362-A30C-FCAFB58BFA29Q36922092-B500492E-0C67-4AA2-93BF-906DC15B2711Q37007828-4253DF19-C59F-439C-A957-15867573F181Q37120413-5C3F481E-93C4-4DC6-A86B-B5C2715AA753Q37190236-17B835C0-E34B-48A6-8BB2-68BDD1203C2DQ37249049-AA265575-A1B3-41AE-A260-2DF77D6C5D81Q37492231-736AA190-D4C6-4C77-94DD-DBC4EACBFE94Q37672563-4BC1F79F-6E33-41EC-9A27-66A68E464C9EQ38703517-EA5EE112-BF5C-45F0-AB41-2D0A5E8C1AD0Q38827600-54BE0353-9DDE-4CED-9FCA-7171770FE864Q39044711-77A2254C-3AB7-4DF0-B71C-91CD1F2838CEQ45866227-9D60C1C6-512A-4A6D-BA45-3BA88BE6957CQ46117098-FDBC056C-1487-4F25-BD15-0C9F3A38F83BQ48246087-AD694C8A-CC22-4928-94F6-1052B3C07E0EQ48355318-FB63815B-F979-4D5A-910E-116E7B233836Q58792549-093D20EA-255F-48FF-92AD-79AF9CF2C431
P2860
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
@en
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.
@nl
type
label
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
@en
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.
@nl
prefLabel
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
@en
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study.
@nl
P2093
P2860
P1476
Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study
@en
P2093
Betty Ortiz-Conde
Bruce Crise
Carrie Bonomi
Chi-Ping Day
Dominic Esposito
Glenn Merlino
John Carter
Melinda Hollingshead
P2860
P304
P356
10.1111/J.1755-148X.2009.00545.X
P577
2009-01-19T00:00:00Z